Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension



Cover Illustration

Client: The Lancet Infectious Diseases
               
               Issue 8, August 2025 




︎          ︎︎︎         ︎︎︎